FINWIRES · TerminalLIVE
FINWIRES

$JWEL.TO

5 stories mentioning JWEL.TOUpdated just now

Every FINWIRES story that references JWEL.TO, newest first.

Mining & Metals

TSX up 240 Points at Midday as Materials, Healthcare, Lead Gains

The Toronto Stock Exchange is up 240 points at midday, led by gains in the materials and healthcare sectors both up 1.4%.The telecoms sector is the worst performer, down 1.2%.In stocks, Blackberry (BB.TO) has jumped 20% to a multi-year high of C$14.63 per share, and is the most actively traded issue on the TSX, after it reported higher first-quarter earnings and revenue, and raised its full year revenue guidance.Vitamin company Jamieson Wellness (JWEL.TO) is also up 12% to a multi-year high of $40.70 after it issued a statement overnight Wednesday confirming it had received an unsolicited proposal to acquire the company.

S&P/TSX CompositeS&P/TSX Composite$BB.TO$JWEL.TO
Mining & Metals

Jamieson Wellness Price Target Edges up to $44.00 at National Bank

National Bank has raised its price target on the shares of Jamieson Wellness (JWEL.TO) by $0.50, to $44.00, after the company reported a first-quarter earnings beat.The results reflect Jamieson's expectations - beating growth in China again, writes analyst Nathan Po, who is maintaining an outperform rating on the company.Po notes that Jamieson operates in the vitamins, minerals and supplements (VMS) category, which is resilient. The company continues to deliver on ambitious growth plans, while navigating the current tariff regime and consumer uncertainty.Price: $34.65, Change: $+0.72, Percent Change: +2.12%

$JWEL.TO
Mining & Metals

Earnings Flash (JWEL.TO) Jamieson Wellness Posts Q1 Adjusted EPS C$0.17 per Share; Diluted EPS $0.21

$JWEL.TO
Mining & Metals

Earnings Flash (JWEL.TO) Jamieson Wellness Reports Q1 Consolidated Revs C$169.8M, Up 16.3% YoY

$JWEL.TO
Mining & Metals

Stifel Canada Maintains Buy Rating, $45.00 Price Target on Jamieson Wellness in Q1 Preview

Stifel Canada is maintaining its buy rating and $45.00 price target on the shares of Jamieson Wellness (JWEL.TO) ahead of the company reporting its first-quarter results on May 7.Analyst Justin Keywood forecasts 11.5% organic growth, to $163 million, with potential upside from a high flu prevalence. Adj. EBITDA margin of 12.6% is also forecast. Keywood notes the first quarter is the lowest margin quarter as ordering patterns are more pronounced with greater scale for the second to fourth quarters.Jamieson offers pure-play exposure to the "Mega Health & Wellness" trend: it is the largest vitamin company in Canada with 3x market share vs. the next largest competitor. Young consumers are entering the VMS (vitamins, minerals and supplements) category early, where historically, demand has been correlated with age. All of this is contributing and setting up for a "confluence of positive tailwinds," he writes.Price: $33.74, Change: $+0.12, Percent Change: +0.36%

$JWEL.TO

Track with the FINWIRES app suite